South America Lipidomics Equipment Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Targeted and Untargeted), Offerings {MS-Based Lipidomics Techniques [Mass Spectrometers Equipped with Ion Sources (Turbo-) ESI/Nano-ESI/APCI, Aut

South America Lipidomics Equipment Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Targeted and Untargeted), Offerings {MS-Based Lipidomics Techniques [Mass Spectrometers Equipped with Ion Sources (Turbo-) ESI/Nano-ESI/APCI, Autosamplers, Micropumps, UV Detectors, UPLC, Variable-Length Fluorescence Detectors, and Others], Assays For Lipid Metabolism, Lipid Flux Using Heavy Isotope-Labeled Precursors, Software & Services, and Others}, Services (Biomarker Identification, Bioinformatic Analysis & Data Interpretation, Molecular Analysis of a Broad Spectrum of Phospholipids (Lipid Fingerprinting), Analysis & Identification of Unusual Lipids, Semiquantitative & Quantitative Analysis, Lipid Flux Studies, and Others), and End User (Molecular Research, Cellular Research, Clinical Research, Tissue & Organ Research, Data Research, Organism Research, Technical Services & Prototyping, Production, and Others)

The SAM lipidomics equipment market is expected to grow from US$ 86.99 million in 2022 to US$ 181.59 million by 2028. It is estimated to register a CAGR of 13.1% from 2022 to 2028.

Growing Use of Fully Automated Lipidomics Equipment is Fueling the SAM Lipidomics Equipment Market

Earlier, the development of automated mass spectrometer solutions mainly focused on pre- and post-analytical areas. Shimadzu, Thermo Fisher, Tecan Group, Agilent, and SCIEX have introduced semiautomated mass spectrometers in the last few years. In 2022, Thermo Fisher launched Cascadion SM Clinical Analyzer, a fully automated system designed for simplifying clinical testing processes; currently, only one vitamin D assay can be run on this Thermo Fisher analyzer. The Cascadion features automated sample preparation, dedicated assays, and LIS connectivity. The launch of such fully automated systems has created the scope for the complete automation of lipidome characterization. Thus, automated lipidomics equipment is likely to emerge as a new trend in the SAM lipidomics equipment market during the forecast period.

SAM Lipidomics Equipment Market Overview

The SAM lipidomics equipment market has been categorized into Brazil, Argentina, and the Rest of SAM. Brazil dominated the market share in 2022. Brazil has made significant developments in the pharmaceutical sector owing to the country's economic policies and reforms, solid hold in domestic pharmaceutical production, and increase in healthcare expenditure. For instance, as per the International Trade Administration (ITA), Brazil is the largest healthcare market in Latin America and spends 9.1% of its GDP on healthcare. Brazil is the largest pharmaceutical market in Latin America and has improved its infrastructure and scientific and technological capabilities. It has created a sustainable strategy to promote drug discovery research activities. Thus, the growing pharmaceutical industry landscape will support Brazil's lipidomics equipment market growth. Furthermore, various organizations are regularly encouraging lipidomics studies through international conferences and education programs to transform the health sector by using lipidomics, which is boosting the growth of the lipidomics market in the country. For instance, the Laboratory of Bioanalytics and Integrated Omics (LaBIOmics), Brazil, integrates mass spectrometry-based omics sciences to understand psychiatric/neurodegenerative disorders and alternative treatments for these illnesses. Thus, the factors above are expected to boost the lipidomics equipment market growth.

SAM Lipidomics Equipment Market Revenue and Forecast to 2028 (US$ Million)

SAM Lipidomics Equipment Market Segmentation

The SAM lipidomics equipment market is segmented based on type, offerings, services, end user, and country.

Based on type, the SAM lipidomics equipment market is bifurcated into targeted and untargeted. The targeted segment held a larger market share in 2022.

Based on offerings, the SAM lipidomics equipment market is segmented into MS-based lipidomics techniques, assays for lipid metabolism, lipid flux using heavy isotope-labeled precursors, software & services, and others. The MS-based lipidomics techniques segment held the largest market share in 2022. The MS-based lipidomics techniques segment is further categorized into mass spectrometers equipped with ion sources (turbo-) ESI/nano-ESI/APCI, autosamplers, micropumps, UV detectors, UPLC, variable-length fluorescence detectors, and others.

Based on services, the SAM lipidomics equipment market has been segmented into biomarker identification, bioinformatic analysis & data interpretation, molecular analysis of a broad spectrum of phospholipids (lipid fingerprinting), analysis & identification of unusual lipids, semiquantitative & quantitative analysis, lipid flux studies, and others. The biomarker identification segment held the largest market share in 2022.

Based on end user, the SAM lipidomics equipment market is segmented into molecular research, cellular research, clinical research, tissue & organ research, data research, organism research, technical services & prototyping, production, and others. The molecular research segment held the largest market share in 2022.

Based on country, the SAM lipidomics equipment market has been categorized into Brazil, Argentina, and the Rest of SAM. Our regional analysis states that Brazil dominated the market in 2022.

Agilent Technologies, Inc.; Bruker; Cayman Chemical; Creative Proteomics; IonBench; PerkinElmer Inc.; Sciex; Shimadzu Corporation.; and Thermo Fisher Scientific Inc. are among the leading companies operating in the SAM lipidomics equipment market.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the SAM lipidomics equipment market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the SAM lipidomics equipment market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth SAM market trends and outlook coupled with the factors driving the lipidomics equipment market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution